Think tank questions polyclinic plans
June 6, 2008A government strategy to transform primary care in England has been dealt a blow by a respected think tank, which …
Erbitux set for first line treatment of colorectal cancer
June 5, 2008Sales and Marketing Cancer, Merck Serono
Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …
Data boost for Avastin
June 5, 2008Sales and Marketing
A new study has confirmed that Roche's Avastin significantly extends time without disease progression for women with metastatic breast cancer. …
Latest news from Datamonitor
June 3, 2008Sales and Marketing
Drug distribution restricted as manufacturers attempt to guard supply chain Ideally, drug supply should be a simple and transparent chain …
Sanofi fights to block generic Plavix in Germany
June 3, 2008Sales and Marketing
Sanofi-Aventis is taking legal action to prevent the launch of a generic competitor to its blockbuster Plavix in Germany. At …
Close to home: the UK’s regional NHS influencers
June 3, 2008Sales and Marketing NICE, UK, healthcare, influencers, regional
With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …
Roche increases stake in Chugai
May 30, 2008Sales and Marketing
Roche is strengthening its hold over Japanese drug firm Chugai, increasing its stake in the company from 50.1% to 59.9%. …
A million more patients to get statins
May 30, 2008Sales and Marketing
Statin prescribing could be set to increase massively once again following new NICE guidance on cholesterol-lowering treatments. An extra 1.5 …
Schering-Plough to exploit new NICE transparency
May 30, 2008Sales and Marketing
NICE has recommended two anti-TNF treatments for ankylosing spondylitis, the painful and progressive rheumatic disease, but has excluded a third …
BMA rails against polyclinics
May 30, 2008Doctors have come together to attack plans to introduce polyclinics to London, claiming the reforms are not proven to improve …
Merck’s odanacatib shows promise in cancer
May 30, 2008Research and Development, Sales and Marketing
Merck's odanacatib (MK-0822) has shown promising results in phase II trials in treating breast cancer which has spread to bones. …
Groundbreaking pharma-NHS collaboration launched in Nottingham
May 30, 2008ABPI, ABPI Outreach Programme, AstraZeneca, Boehringer Ingelheim, COPD, GlaxoSmithKline, INFORCE, Nottingham, Nycomed, Pfizer, joint working
A group of pharmaceutical companies have joined forces with Nottingham healthcare services to help improve care for patients with chronic …
7 principles in marketing to the new NHS
May 28, 2008Sales and Marketing NHS, healthcare, marketing
Developing a successful market access strategy has become the Holy Grail for brand teams across the UK pharmaceutical industry.
Latest news from Datamonitor
May 28, 2008Sales and Marketing em, hc
Potential lung cancer epidemic looming in AsiaLung cancer is the leading cause of cancer-related mortality throughout much of the industrialized …
Lilly unveils streamlined business structure
May 22, 2008Sales and Marketing lilly, restructure
A simplified and slimmed-down corporate structure has been unveiled by US pharmaceutical firm Lilly, which says it hopes to cut …
Cervical cancer awareness campaign launched
May 22, 2008Medical Communications
PR agency Consolidated has been hired to help publicise the forthcoming NHS cervical cancer immunisation programme. The Department of Health …
MPs back hybrid embryo research
May 22, 2008Research using 'hybrid' human/animal embryos has been given the green light by MPs. Politicians, including the Labour and Conservative leaders, …
Gardasil or Cervarix? Government decision imminent
May 22, 2008A decision on which of the two vaccines for cervical cancer will be used in the nationwide immunisation campaign is …
Pfizer signs diabetes and cancer partnership with biotech
May 21, 2008Research and Development
Pfizer has announced an alliance with US biotech Five Prime Therapeutics, in a move to boost its pipeline and become …
Being ‘bumped’: the new alternative to redundancy
May 21, 2008Business Services careers, recruitment, redundancy
The pharmaceutical industry is currently in the midst of major restructuring, with many of the sector’s leading companies in the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
